ASH 2021 Conference Coverage on VuMedi

 

ASH 2021 Conference Coverage on VuMedi
R

ASH 2021 Highlights on Concurrent Pembrolizumab With AVD for Untreated Classical Hodgkin Lymphoma

By ASH 2021 Conference Coverage on VuMedi FEATURING Ryan C. Lynch
By ASH 2021 Conference Coverage on VuMedi FEATURING Ryan C. Lynch
82 views
December 20, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip
Lymphoma
05:05

A Multi-Institution Analysis of Relapsed Lymphoma Occurring During P…

ASH 2021 Conference Coverage on VuMedi

F. Farooq

15 views
07:23

ASH 2021 Five-Year Follow-Up of Keynote-087: Pembrolizumab Monothera…

ASH 2021 Conference Coverage on VuMedi

A. Herrera

281 views
24:07

ASH 2021 Highlights: CAR-T as 2L Therapy in R/R Aggressive NHL

ASH 2021 Conference Coverage on VuMedi

N. Ahmed

91 views
12:04

ASH 2021 Update on the Safety and Efficacy of CD37-Targeting Naratux…

ASH 2021 Conference Coverage on VuMedi

M. Y. Levy

121 views
14:15

ASH 2021 Update on the Outcomes & Treatment Patterns in Pts With Agg…

ASH 2021 Conference Coverage on VuMedi

J. Zurko

221 views
10:55

ASH 2021 Update on a Phase II Study of OB-VEN in Patients With HTB-F…

ASH 2021 Conference Coverage on VuMedi

C. Portell

76 views
10:52

ASH 2021 Updates on Managing R/R DLBCL: Surveying Treatment Landscape

ASH 2021 Conference Coverage on VuMedi

A. Goy

24 views
09:47

ASH 2021 Update on Brexucabtagene Autoleucel for R/R MCL: Real-World…

ASH 2021 Conference Coverage on VuMedi

Y. Wang

23 views
06:00

ASH 2021 Highlights on Concurrent Pembrolizumab With AVD for Untreat…

ASH 2021 Conference Coverage on VuMedi

R. C. Lynch

82 views
17:50

ASH 2021 Updates on Allogeneic CAR-T PBCAR0191 With Intensified Lymp…

ASH 2021 Conference Coverage on VuMedi

B. Shah

66 views
10:59

ASH 2021: Glofitamab + R-CHOP Induces High Response Rates With Minim…

ASH 2021 Conference Coverage on VuMedi

N. Ghosh

157 views
09:46

ASH 2021 Frontline Treatment With Pembrolizumab Followed by AVD Chem…

ASH 2021 Conference Coverage on VuMedi

P. Allen

243 views
08:18

ASH 2021 Updates on the Umbralisib + Ublituximab Combo in R/R MZL: R…

ASH 2021 Conference Coverage on VuMedi

J. Chavez

63 views
10:20

ASH 2021 Highlights on Real-World Case Studies in ctDNA

ASH 2021 Conference Coverage on VuMedi

P. Blombery

81 views
06:32

ASH 2021 Updates on CD30-Directed CAR T-Cells for Pediatric Patients…

ASH 2021 Conference Coverage on VuMedi

G. Hucks

43 views